Mostrando 1 - 10 resultados de 10 para a busca 'D. Paul Harkin (14873531)', tempo de busca: 0.01s Refinar Resultados
  1. 1
    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors por Katrina M. Lappin (9340394)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  2. 2
    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors por Katrina M. Lappin (9340394)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  3. 3
    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors por Katrina M. Lappin (9340394)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  4. 4
    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors

    Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors por Katrina M. Lappin (9340394)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  5. 5
    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  6. 6
    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  7. 7
    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  8. 8
    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  9. 9
    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:
  10. 10
    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification

    Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

    Publicado em 2025
    Outros Autores:
    Salvar na lista
    Na minha lista:

Ferramentas de busca: